Publications

Inequities in childhood immunisation coverage associated with socioeconomic, geographic, maternal, child, and place of birth characteristics in Kenya.

Allan, S; ADETIFA, IM O; ABBAS, K;

2021

BMC infectious diseases, (2021).21 1 10.1186/s12879-021-06271-9.

Evaluation of a Campylobacter jejuni N-glycan-ExoA glycoconjugate vaccine to reduce C. jejuni colonisation in chickens.

Vohra, P; Chintoan-Uta, C; Bremner, A; MAURI, M; TERRA, VS; CUCCUI, J; WREN, BW; Vervelde, L; Stevens, MP; Glycoengineering of Veterinary Vaccines Consortium,;

2021

Vaccine, (2021).39 51 10.1016/j.vaccine.2021.10.085.

Optimal human papillomavirus vaccination strategies to prevent cervical cancer in low-income and middle-income countries in the context of limited resources: a mathematical modelling analysis.

Drolet, M; Laprise, J-F; Martin, D; JIT, M; Bénard, É; Gingras, G; Boily, M-C; Alary, M; Baussano, I; Hutubessy, R; Brisson, M;

2021

The Lancet. Infectious diseases, (2021).21 11 10.1016/S1473-3099(20)30860-4.

Otitis media outcomes of a combined 10-valent pneumococcal Haemophilus influenzae protein D conjugate vaccine and 13-valent pneumococcal conjugate vaccine schedule at 1-2-4-6 months: PREVIX_COMBO, a 3-arm randomised controlled trial.

Leach, AJ; MULHOLLAND, EK; Santosham, M; Torzillo, PJ; McIntyre, P; Smith-Vaughan, H; Wilson, N; Arrowsmith, B; Beissbarth, J; Chatfield, MD; Oguoma, VM; Morris, PS;

2021

BMC pediatrics, (2021).21 1 10.1186/s12887-021-02552-z.

The role of maturity in adolescent decision-making around HPV vaccination in France.

KARAFILLAKIS, E; Peretti-Watel, P; Verger, P; CHANTLER, T; LARSON, HJ;

2021

Vaccine, (2021).39 40 10.1016/j.vaccine.2021.08.096.

Vaccine safety in the next decade: why we need new modes of trust building.

LARSON, HJ; Sahinovic, I; Balakrishnan, MR; Simas, C;

2021

BMJ global health, (2021).6 Suppl 10.1136/bmjgh-2020-003908.

How can the public health impact of vaccination be estimated?.

Londono, SE; Li, X; Toor, J; Villiers, MD; Nayagam, S; Hallett, T; Abbas, K; JIT, M; KLEPAC, P; Jean, K; Garske, T; Ferguson, N; Gaythorpe, K;

2021

medRxiv (2021). 10.1101/2021.01.08.21249378.

The importance of supplementary immunisation activities to prevent measles outbreaks during the COVID-19 pandemic in Kenya.

MBURU, CN; OJAL, J; Chebet, R; Akech, D; Karia, B; Tuju, J; Sigilai, A; ABBAS, K; JIT, M; FUNK, S; Smits, G; Van Gageldonk, PG M; Van der Klis, FR M; Tabu, C; Nokes, DJ; LSHTM CMMID COVID-19 Working Group,; SCOTT, J; FLASCHE, S; ADETIFA, I;

2021

BMC medicine, (2021).19 1 10.1186/s12916-021-01906-9.

Evidence Review on Single-Dose HPV Vaccination from Clinical Trials.

WATSON-JONES, D;

2021

(2021).

Replication Data for: Prevalence of SARS-CoV-2 Antibodies from a one-year National Serosurveillance of Kenyan Blood Transfusion Donors.

Uyoga, S; ADETIFA, IM O; OTIENDE, M; Gitonga, JN; Mugo, D; Nyagwange, J; Karanja, HK; Tuju, J; Makale, J; Aman, R; Mwangangi, M; Amoth, P; Kasera, K; Ng'ang'a, W; Chege, E; Yegon, C; Kithi, K; Odhiambo, E; Rotich, T; Orgut, I; Kihara, S; BOTTOMLEY, C; Kagucia, EW; GALLAGHER, KE; Etyang, A; ... SCOTT, JA G.

2021

, Harvard Dataverse (2021).